Bitcoin (CRYPTO: BTC) bull and BitMex co-founder Arthur Hayes says President Trump’s Venezuela move creates a simple trade: if liquidity increases while gas prices stay cheap, Bitcoin moons; if oil spikes, the rally dies. The 10% Rule That Decides Elections…
Anheuser-Busch Inbev (NYSE:BUD) shares climbed Tuesday as the company announced a major production and economic investment in Jacksonville, Florida. The firm said it will spend $30 million to upgrade brewing and packaging operations at its Jacksonville brewery and can plant,…
Meta Platforms Inc. (NASDAQ:META) is delaying its planned international rollout of the Ray-Ban Display smart glasses as demand in the U.S. has rapidly outpaced supply, forcing the company to rethink its global launch timeline. Meta had initially targeted early 2026…
Wall Street has kicked off 2026 on a strong footing, with large-cap indexes heading toward a third straight session of gains on Tuesday. By midday trading in New York, the Dow Jones Industrial Average rallied nearly 1%, extending record highs…
STAAR Surgical Company (NASDAQ:STAA) announced Tuesday that it did not receive the necessary stockholder votes to approve the merger agreement with Alcon Inc. (NYSE:ALC) at the Special Meeting of Stockholders. STAAR intends to terminate its merger agreement with Alcon. No termination…
Health care ETFs could emerge as one of the stronger performers in 2026 as investors grow cautious about pricey AI stocks. • State Street Health Care Select Sector SPDR ETF shares are trending higher. Why is XLV stock advancing? Analysts,…
U.S. airlines are entering 2026 with tight capacity and resilient premium demand, creating a setup where carriers with pricing power and strong cash generation are poised to pull further ahead of weaker peers. Bank of America Securities analyst Andrew G.…
Whales with a lot of money to spend have taken a noticeably bullish stance on Goldman Sachs Group. Looking at options history for Goldman Sachs Group (NYSE:GS) we detected 149 trades. If we consider the specifics of each trade, it…
Apogee Therapeutics, Inc. (NASDAQ:APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients with mild-to-moderate asthma. The trial also evaluated fractional exhaled nitric oxide (FeNO)…
Silver's historic rally shows no signs of cooling as the new year begins. After a blockbuster 2025 that saw silver shatter decade-old resistance levels, it has extended its gains by another 13% in the first week of 2026 alone. EXK…